Wharton's jelly mesenchymal stem cells from umbilical cord tissue demonstrated remarkable anti-aging effects by specifically reprogramming pro-inflammatory fibroblast subpopulations in aged skin. The cells restored cellular function, increased collagen deposition, rebalanced collagen I/III ratios, and downregulated the circadian rhythm gene Dbp that drives inflammatory fibroblast activity. Single-cell analysis revealed fibroblasts as central communication hubs orchestrating skin aging through inflammatory signaling. This represents a significant advance in regenerative medicine, offering the first mechanistic explanation for how umbilical cord-derived stem cells achieve skin rejuvenation at the cellular subset level. The identification of specific fibroblast subpopulations as aging drivers opens new therapeutic targets beyond current broad-spectrum approaches. However, translation faces regulatory hurdles since these cells require invasive administration and extensive processing. The D-galactose aging model, while useful, may not fully recapitulate natural human skin aging patterns. Most compelling is the circadian connection—Dbp gene disruption suggests aging fibroblasts lose temporal regulation, potentially explaining why skin repair diminishes with age and pointing toward chronotherapy approaches for skin health.